Deng, M., Zhang, M., Xu-Monette, Z. Y., Pham, L. V., Tzankov, A., Visco, C., . . . Young, K. H. (2020). XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53. BMC.
Chicago-stil citatDeng, Manman, et al. XPO1 Expression Worsens the Prognosis of Unfavorable DLBCL That Can Be Effectively Targeted By Selinexor in the Absence of Mutant P53. BMC, 2020.
MLA-referensDeng, Manman, et al. XPO1 Expression Worsens the Prognosis of Unfavorable DLBCL That Can Be Effectively Targeted By Selinexor in the Absence of Mutant P53. BMC, 2020.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.